{"transactions":[{"id":921951,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":108000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921950,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921949,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921948,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":12132,"price":4.24,"value":51439.68,"ownership":{"direct":true},"balance_after":79329,"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921947,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":41333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":91461,"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":1284913,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":120100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2025 such that the option is fully vested on January 31, 2029."}],"balance_after":120100,"derivative":{"exercise_price":3.06,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":120100},"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1284912,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1284911,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":33333,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1284910,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":12062,"price":3.06,"value":36909.72,"ownership":{"direct":true},"balance_after":50128,"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1284909,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects shares received upon the satisfaction of performance criteria and time-vesting requirements associated with previously granted performance restricted stock units (\"PSUs\")."}],"balance_after":62190,"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1284908,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:06.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":54190,"source":{"system":"sec-edgar","filing":"0000950170-25-013844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017025013844/ownership.xml","form_type":"4"}},{"id":1661793,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:26:53.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":120100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028."}],"balance_after":120100,"derivative":{"exercise_price":4.16,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":120100},"source":{"system":"sec-edgar","filing":"0000950170-24-010969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017024010969/ownership.xml","form_type":"4"}},{"id":1661792,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-02T21:26:53.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":66666,"derivative":{"underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0000950170-24-010969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017024010969/ownership.xml","form_type":"4"}},{"id":1661791,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:26:53.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":12477,"price":3.8394,"value":47904.1938,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 15, 2022."}],"balance_after":20857,"source":{"system":"sec-edgar","filing":"0000950170-24-010969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017024010969/ownership.xml","form_type":"4"}},{"id":1661790,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:26:53.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":33334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":33334,"source":{"system":"sec-edgar","filing":"0000950170-24-010969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000095017024010969/ownership.xml","form_type":"4"}},{"id":2036206,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T18:38:09.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027."}],"balance_after":140000,"derivative":{"exercise_price":4.63,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000899243-23-003629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000089924323003629/doc4.xml","form_type":"4"}},{"id":2036205,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:38:09.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-003629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000089924323003629/doc4.xml","form_type":"4"}},{"id":2416775,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T17:15:52.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022."}],"balance_after":120000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-22-004183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000089924322004183/doc4.xml","form_type":"4"}},{"id":2888774,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-01T16:50:45.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":71750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021."}],"balance_after":71750,"derivative":{"exercise_price":73,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":71750},"source":{"system":"sec-edgar","filing":"0000899243-21-003866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000089924321003866/doc4.xml","form_type":"4"}},{"id":2997479,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-30T17:40:14.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 equal monthy installments following October 29, 2020."}],"balance_after":40000,"derivative":{"exercise_price":24,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-20-029953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000089924320029953/doc4.xml","form_type":"4"}},{"id":3686841,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-25T16:05:05.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal quarterly installments over the first four years after the vesting commencement date, January 23, 2019."}],"balance_after":30750,"derivative":{"exercise_price":3.51,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":30750},"source":{"system":"sec-edgar","filing":"0001104659-19-003410","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465919003410/a4.xml","form_type":"4"}},{"id":4073891,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-06T16:26:05.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal quarterly installments over the first four years after the vesting commencement date, February 2, 2018."}],"balance_after":20250,"derivative":{"exercise_price":14.23,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0001104659-18-006858","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918006858/a4.xml","form_type":"4"}},{"id":4081946,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":false,"shares":2499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original option grant for 13,333 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, March 14, 2017."}],"balance_after":10834,"derivative":{"exercise_price":6.98,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":2499},"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081945,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":false,"shares":3262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original option grant for 13,047 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, July 1, 2016."}],"balance_after":8155,"derivative":{"exercise_price":4.1,"expiration_date":"2026-08-29","underlying":"Common Stock","underlying_shares":3262},"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081944,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":false,"shares":8055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original option grant for 32,222 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015."}],"balance_after":12084,"derivative":{"exercise_price":1.53,"expiration_date":"2025-06-11","underlying":"Common Stock","underlying_shares":8055},"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081943,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original option grant for 3,555 option shares vests in equal quarterly installments over the first four years after the vesting commencement date, January 2, 2015."}],"balance_after":889,"derivative":{"exercise_price":1.62,"expiration_date":"2024-12-15","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081942,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":true,"shares":2499,"price":6.98,"value":17443.02,"ownership":{"direct":true},"balance_after":71083,"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081941,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":true,"shares":3262,"price":4.1,"value":13374.2,"ownership":{"direct":true},"balance_after":68584,"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081940,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":true,"shares":8055,"price":1.53,"value":12324.15,"ownership":{"direct":true},"balance_after":65322,"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}},{"id":4081939,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2018-02-01T16:01:50.000Z","date":"2018-01-30","kind":"exercise","acquired":true,"shares":889,"price":1.62,"value":1440.18,"ownership":{"direct":true},"balance_after":57267,"source":{"system":"sec-edgar","filing":"0001104659-18-005845","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000110465918005845/a4.xml","form_type":"4"}}]}